Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • prescription drug

    Tag: prescription drug

    You Searched For "prescription drug"
    Sunovion Pharma resubmits application to USFDA for sublingual Apomorphine to treat Parkinsons disease

    Sunovion Pharma resubmits application to USFDA for sublingual Apomorphine to treat Parkinsons disease

    Farhat Nasim25 Dec 2019 9:15 AM IST
    New Delhi: Sunovion Pharmaceuticals Inc. (Sunovion) recently announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug...
    Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over

    Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over

    Medical Dialogues Bureau23 Sept 2019 10:00 AM IST
    Ranitidine is an Over-The-Counter (OTC) and prescription drug which decreases the amount of acid created by the stomach.Hyderabad: Dr Reddy's...
    GSK receives USFDA panel backing for OTC nicotine oral spray for smoking de-addiction

    GSK receives USFDA panel backing for OTC nicotine oral spray for smoking de-addiction

    Farhat Nasim19 Sept 2019 9:30 AM IST
    Johnson & Johnson (JnJ), GSK Plc's developmental partner, sell the over-the-counter nicotine oral spray in 45 countries, excluding the United...
    Strides Pharma infuses Rs 15.50 crore in Fairmed for 70pc stake

    Strides Pharma infuses Rs 15.50 crore in Fairmed for 70pc stake

    Medical Dialogues Bureau12 Sept 2019 10:00 AM IST
    The company's step-down subsidiary Strides Pharma Global has acquired a majority stake in Fairmed Healthcare AG which has a portfolio of generic...
    Novartis wins USFDA approval for first PI3K inhibitor for breast cancer

    Novartis wins USFDA approval for first PI3K inhibitor for breast cancer

    Farhat Nasim27 May 2019 6:10 PM IST
    The drug, alpelisib, to be marketed under the brand name Piqray, belongs to a class of drugs known as PI3K inhibitors and is the first of its kind to...
    GSK, Pfizer gets CCI approval for consumer healthcare JV formation

    GSK, Pfizer gets CCI approval for consumer healthcare JV formation

    Garima25 May 2019 9:45 AM IST
    After the deal, GSK will have a majority controlling equity interest of 68 per cent in the combined consumer healthcare business, while Pfizer will...
    Group with consumer friendly vibe pushes drugmakers message

    Group with consumer friendly vibe pushes drugmakers message

    Farhat Nasim18 March 2019 9:00 AM IST
    Drug prices may provide a rare bipartisan issue on which Congress and the White House could collaborate on legislation. WASHINGTON: Outside groups...
    New law for labelling Drugs, Fixed Dose Combinations: Govt issues Gazette

    New law for labelling Drugs, Fixed Dose Combinations: Govt issues Gazette

    Meghna A Singhania8 March 2019 3:12 PM IST
    Objections and suggestions, if any, may be addressed to the Under Secretary (Drugs), Ministry of Health and Family Welfare, Government of India, Room...
    Labelling norms for high-risk medicines made Stringent, Check out details

    Labelling norms for high-risk medicines made Stringent, Check out details

    Ruby Khatun Khatun23 May 2018 4:59 PM IST
    The new rules will be applicable to medicines such as Narcotic analgesics, hypnotics, sedatives, tranquillizers, corticosteroids, hormones,...
    US employers say CVS-Aetna deal would affect health-benefits decisions: survey

    US employers say CVS-Aetna deal would affect health-benefits decisions: survey

    Ruby Khatun Khatun20 Dec 2017 9:45 AM IST
    NEW YORK: CVS Corp's proposed purchase of Aetna Inc will affect decision-making by a majority of large and mid-size U.S. corporations on employee...
    Zydus gets regulatory nod to market Lipaglyn in Mexico

    Zydus gets regulatory nod to market Lipaglyn in Mexico

    Ruby Khatun Khatun11 Nov 2017 10:32 AM IST
    New Delhi: Drug firm Zydus said it has received approval from the Mexican regulatory authority to market Lipaglyn (Saroglitazar Magnesium) used for...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok